Weekender 5/15/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. It’s Been a Banner Week for the New Jersey Life Sciences Community At the State level, Biosimilars legislation (A2477) was approved by the Assembly in a unanimous vote (72-0). This legislation allows pharmacists to substitute biosimilar products as long as the… Read the full article


Weekender 5/8/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Eli Lilly Receives Fourth FDA Approval For CYRAMZA Eli Lilly and Company received its fourth U.S. Food and Drug Administration (FDA) approval for CYRAMZA (ramucirumab), now also indicated in combination with FOLFIRI (irinotecan, folinic acid and 5-fluorouracil) chemotherapy for the treatment… Read the full article


Weekender 5/1/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. A Pair of FDA Approvals for New Jersey: The Medicines Company announced that they have received FDA approval for IONSYS (fentanyl iontophoretic transdermal system), the first needle-free, patient-controlled, pre-programmed fentanyl delivery system, for the short-term management of acute post-operative pain in adult patients requiring… Read the full article


Weekender 4/24/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Big News for BioNJ Member Advaxis: Advaxis was recently awarded two Vaccine Industry Excellence (ViE) Awards. The company finished first in “Best Financing Deal” and “Best Early-Stage Biotech;” and was Highly Commended in the “Best Biotech CEO” category. Congrats! Three BioNJ… Read the full article


Weekender 4/17/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The Biotechnology Industry Organization (BIO) announced its selection of Representative Leonard Lance as Legislator of the Year for 2015. BioNJ was proud to nominate the Congressman for this honor, which is so well deserved given his leadership on so many fronts… Read the full article


Weekender 4/10/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. On April 22, BioNJ, BDO, NJEDA, and Tax Transfer Corporation will hold an educational Webinar entitled Don’t Leave Money on the Table! that will provide up-to-date information on important NOL Program changes. The Webinar starts at 10 a.m. and will feature BioNJ President… Read the full article


Weekender 4/3/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. The biotech industry opens the NASDAQ! BioNJ’s President and CEO Debbie Hart joined other biotech colleagues, including Jim Greenwood, President and CEO of BIO; Nathan Tinker, Executive Director of NewYorkBIO and Chris Molineaux, President of Pennsylvania BIO, to officially open trading… Read the full article


Weekender 3/27/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Congratulations to the Coriell Institute for Medical Research in Camden, for its announcement on March 16 that it has won a $14 million grant from the National Institutes of Health to advance the work of the Institute, which maintains a diverse… Read the full article


Weekender 3/13/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Let’s start the good news with another FDA approval in 2015, shall we? Congratulations to Actavis for its approval of AVYCAZ, a treatment for adult patients with complicated intra-abdominal infections and complicated urinary tract infections. This week’s excitement continues with the… Read the full article


Weekender 3/6/15

To Our New Jersey Life Sciences Community: Welcome to another edition of The Weekender. Not even another snowy lead-in to the weekend can stop the good news radiating from our Members like the sun we are all hoping to see very, very soon! Congrats to our Members Bristol-Myers Squibb Company as well as Actavis on… Read the full article